Keros Therapeutics
Social media
Keros Therapeutics Logo
About Keros Therapeutics
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta (TGF-β) family of proteins. Its lead product candidate, KER-050, targets cytopenias such as anemia and thrombocytopenia in myelodysplastic syndromes and myelofibrosis. The company is also advancing KER-012 for pulmonary arterial hypertension and cardiovascular disorders, and KER-065 for neuromuscular diseases. Keros Therapeutics aims to address high unmet medical needs in hematological, pulmonary, cardiovascular, and musculoskeletal disorders.
Address
1050 Waltham Street, Suite 302
Lexington, 02421
United States
Year founded
2015
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
